Posted On: 01/08/2015 8:54:59 PM
Post# of 30066
If a deal such as this was made by GC I would exit the stock.....
On August 11, 2014 MannKind entered into an exclusive global licensing agreement with Sanofi for global Afrezza sales.[7] Under the licensing agreement, MannKind received $150 million cash from Sanofil, in exchange for sharing profits and losses of sales of Afrezza, with 65% for Sanofil and 35% for MannKind. [8]
http://en.m.wikipedia.org/wiki/MannKind_Corporation
On August 11, 2014 MannKind entered into an exclusive global licensing agreement with Sanofi for global Afrezza sales.[7] Under the licensing agreement, MannKind received $150 million cash from Sanofil, in exchange for sharing profits and losses of sales of Afrezza, with 65% for Sanofil and 35% for MannKind. [8]
http://en.m.wikipedia.org/wiki/MannKind_Corporation
(0)
(0)
